Molecular Dynamics Simulations Indicate Inhibitor‐Induced Closure of the TEAD–YAP Interface 2

The interaction of TEAD with its cofactor YAP plays a crucial role in cancer. Several inhibitors have been described as binding to the P-site of TEAD, without directly interacting with the TEAD-YAP interfaces. However, the mechanism of action of those inhibitors remains not fully understood. In this study, we conducted an extensive analysis of available X-ray structures and found that allosteric effects of cocrystalized inhibitors in TEAD cannot be explained by the static information provided by these experimental structures. We then performed molecular dynamics simulations, which are consistent with inhibitors populating a closed conformation in between Y361 and S328, located at the YAP-TEAD binding interface 2. This effect is consistent among different inhibitors and different TEAD subtypes. Our simulations also suggest that YAP binding appears to be associated with the opening of this region, consistent with the effect of palmitic acid. These results support the hypothesis that P-site binders not only restrict protein dynamics but may also inhibit YAP binding by allosterically modulating YAP-TEAD interface 2.

Authors

Institutions

Publication Details

Journal
ChemMedChem
Published
2026-11-10
DOI
https://doi.org/10.1002/cmdc.70571
Primary Topic
Hippo pathway signaling and YAP/TAZ
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular Dynamics Simulations Indicate Inhibitor‐Induced Closure of the TEAD–YAP Interface 2

Jakub Gunera, Timo Heinrich, Jesko Kaiser
ChemMedChem
Hippo pathway signaling and YAP/TAZ
article

Molecular Dynamics Simulations Indicate Inhibitor‐Induced Closure of the TEAD–YAP Interface 2

Jakub Gunera, Timo Heinrich, Jesko Kaiser
article en

Abstract

The interaction of TEAD with its cofactor YAP plays a crucial role in cancer. Several inhibitors have been described as binding to the P-site of TEAD, without directly interacting with the TEAD-YAP interfaces. However, the mechanism of action of those inhibitors remains not fully understood. In this study, we conducted an extensive analysis of available X-ray structures and found that allosteric effects of cocrystalized inhibitors in TEAD cannot be explained by the static information provided by these experimental structures. We then performed molecular dynamics simulations, which are consistent with inhibitors populating a closed conformation in between Y361 and S328, located at the YAP-TEAD binding interface 2. This effect is consistent among different inhibitors and different TEAD subtypes. Our simulations also suggest that YAP binding appears to be associated with the opening of this region, consistent with the effect of palmitic acid. These results support the hypothesis that P-site binders not only restrict protein dynamics but may also inhibit YAP binding by allosterically modulating YAP-TEAD interface 2.

ChemMedChemVol. 21(21)
Merck Healthcare KGaA, Darmstadt (Germany) (DE)
Hippo pathway signaling and YAP/TAZ
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon